Genmab - redOrbit

Amgen and AstraZeneca Announce Collaboration to Jointly Develop and Commercialize Clinical-Stage Inflammation Portfolio

2012-04-02 10:25:18

THOUSAND OAKS, Calif.

MarketsandMarkets: Chronic Lymphocytic Leukemia Therapeutics Market Worth $2.2 Billion by 2020

2011-12-08 05:31:00

DALLAS, December 8, 2011 /PRNewswire/ -- The report "Chronic Lymphocytic Leukemia Therapeutics Market in G8 Countries (2010 - 2020)" analyzes and studies the major market

MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020

2011-11-21 04:30:00

DALLAS, Texas, November 21, 2011 /PRNewswire/ -- The report "Leukemia Therapeutics Market (Acute/Chronic Lymphocytic Leukemia & Acute/Chronic Myeloid Leukemia) Pipeline

Xencor Initiates Phase 1 Study of XmAbÂ®5871 Therapeutic Antibody for the Treatment of Autoimmune Diseases

2011-10-21 07:00:00

MONROVIA, Calif., Oct.

Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6

2011-06-20 07:00:00

BOTHELL, Wash., June 20, 2011 /PRNewswire/ -- Alder Biopharmaceuticals Inc.

News - Genmab

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health